#3873 UTILITY OF BLOOD KETONE MONITORING IN HAEMODIALYSIS PATIENTS UNDER INPATIENT NEPHROLOGY CARE

Abstract Background and Aims There is a lack of evidence regarding the relationship between capillary blood glucose (CBG) >15 mmol/L ketones in maintenance haemodialysis dialysis patients meaning utility ketone measurement this group uncertain. Despite this, guidance published by Joint British Diabetes Society for Inpatient Care (JBDS-IP) 2022 states that should be measured on with diabetes mellitus (DM) who have pre- or post-dialysis CBG >15mmol/L symptoms consistent diabetic ketoacidosis (DKA), acknowledging these can non-specific [1]. We sought to identify if there elevated levels patients, affects levels. Method Maintenance DM admitted single ward over 2 separate month periods were included. Nursing staff recorded using FreeStyle PrecisionPro meter. For each patient, further demographic data collected from electronic patient record. Results 79 measures 30 1 7 patient. 57% (n = 17) male, 37% 11) had T1DM, 80% 24) insulin therapy. The median pre-HD all was 10.5mmol/L (IQR 8.15-15.05), post-HD 9.1mmol/L 6.8-12.95), 0.1mmol/L 0.1-0.2) 0.1-0.3). no significant difference pre-and (p 0.09) (Figure 1). where 21) 0.1 0.2mmol/L respectively 0.45). >20mmol/L 6) 0.1-0.13) 0.2 0.13). <15mmol/L, 0.1-0.2). those <15mmol/L 0.69). Conclusion These results demonstrate (>15mmol/L) nor do they change post haemodialysis. Unwell clearly warrant medical assessment, but are useful aid assessment guide management patients.